.Back to listing

Tue, Jul 05

The Journal of Law and the Biosciences Nearly Doubles Its Previous Impact Factor

The Journal of Law and the Biosciences (JLB) is the first fully open access, peer-reviewed, legal journal focused on the advances at the intersection of law and the biosciences. We are excited to report the JLB received a significant increase in its impact factor jumping from 3.583 last year to 6.066 in 2022.

This new ranking now places the JLB in the top three in four relevant categories:

  • Ethics: 3rd/56 (up from 8th)
  • Law: 2nd/154 (up from 7th)
  • Medical Ethics: 2nd/16 (unchanged)
  • Medicine, Legal: 1st/17 (up from 2nd)


Read the Current Issue


The JLB is a co-venture between Duke University, Harvard University Law School, and Stanford University, and published by Oxford University Press. Nita Farahany, Director of the Duke Initiative for Science & Society and Professor of Law and Philosophy, is one of the three founding co-editors in chief of JLB, with I. Glenn Cohen from Harvard and Hank Greely from Stanford. The JLB editorial board is composed of nearly thirty leading scholars working in law, bioethics, philosophy, neuroscience, psychology, and other disciplines.

The journal contains original and response articles, essays, and commentaries on a wide range of topics, including bioethics, neuroethics, genetics, reproductive technologies, stem cells, enhancement, patent law, and food and drug regulation. The journal accepts submissions year-round. Learn more about the submission process here.